Effect of bezafibrate and clofibrate on the heme-iron geometry of ferrous nitrosylated heme-human serum albumin: an EPR study

J Inorg Biochem. 2001 Apr;84(3-4):293-6. doi: 10.1016/s0162-0134(01)00185-4.

Abstract

The effect of bezafibrate (BZF) and clofibrate (CF), two therapeutic drugs displaying anticoagulant and antihyperlipoproteinemic activities, on the EPR-spectroscopic properties of ferrous nitrosylated heme-human serum albumin (HSA-heme-NO) has been investigated. In the absence of BZF and CF, HSA-heme-NO is a five-coordinate heme-iron system, characterised by an X-band EPR spectrum with a three-line splitting in the high magnetic field region. Addition of BZF and CF to HSA-heme-NO induced the transition towards a six-coordinate heme-iron species characterised by an X-band EPR spectrum with an axial geometry. These data indicate that HSA-heme-NO is a five-coordinate heme-iron system, BZF and CF acting as allosteric effectors, and show that the primary heme binding site and the CF cleft of HSA are conformationally-linked, regardless of their different location.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bezafibrate / pharmacology*
  • Clofibrate / pharmacology*
  • Electron Spin Resonance Spectroscopy*
  • Heme / analogs & derivatives*
  • Heme / chemistry
  • Heme / metabolism*
  • Humans
  • Hypolipidemic Agents / pharmacology
  • Molecular Structure
  • Protein Binding / drug effects
  • Protein Structure, Quaternary / drug effects
  • Protein Structure, Tertiary / drug effects
  • Serum Albumin / chemistry
  • Serum Albumin / drug effects*
  • Serum Albumin / metabolism

Substances

  • Hypolipidemic Agents
  • Serum Albumin
  • Heme
  • nitrosylprotoheme
  • Clofibrate
  • Bezafibrate